AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 OCT 10 - (NewsRx.com & NewsRx.net) --
by Michael Greer, senior medical writer - Hyperattenuated flu viruses transfected with HIV genetic material may be able to help prevent HIV infection, researchers in Austria report.
Boris Ferko and colleagues at Vienna's Institute of Applied Microbiology developed influenza virus-based vaccine vectors "containing an insertion of the 137 C-terminal amino acid residues of the human immunodeficiency virus type 1 (HIV-1) Nef protein into the influenza A virus nonstructural-protein (NS1) reading frame."
This vaccine triggered significant HIV specific immune responses in a murine model, according to their report in the October 2001 edition of the Journal of Virology.
Ferko and coworkers found cytotoxic T-lymphocyte activity specific to both influenza and HIV Nef in the spleens and respiratory tract lymph nodes of vaccinated mice. This response occurred in spite of the hyperattenuated phenotype of the recombinant virus vector, they noted.
Priming with a vector of the H1N1 influenza subtype followed by boosting with a H3N2 subtype vector augmented the antiviral response and extended it to murine urogenital tracts, study data showed. A double dose of H1N1 vectors followed by H3N2 subtype boosting resulted in the production of Nef-specific immunoglobulin G.
Despite the inability of recombinant ...